• Markets
  • icon
  • Companies
RHY · ASX

Rhythm Biosciences Limited (ASX:RHY)

AU$0.092

 0.001 (1.099%)
ASX:Live
15/04/2024 12:56:12 PM
Near Support Near 52 Week Low HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

RHY Overview

RHY Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About RHY

Telephone

Address

Description

Rhythm Biosciences Ltd. engages in the research, development, and commercialization of medical diagnostics technologies. It offers a diagnostic blood test for screening for colorectal cancer under the ColoSTAT brand. The company was founded on June 1, 2017 and is headquartered in Parkville, Australia.

RHY Price Chart

Key Stats

Market Cap

AU$22.88M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.09 - 0.81

Trade Value (12mth)

AU$23,945.00

1 week

-2.15%

1 month

-4.21%

YTD

-28.5%

1 year

-80.64%

All time high

2.03636

Key Fundamentals

EPS 3 yr Growth

6.600%

EBITDA Margin

N/A

Operating Cashflow

-$7m

Free Cash Flow Return

-104.40%

ROIC

-123.30%

Interest Coverage

N/A

Quick Ratio

2.50

Other Data

Shares on Issue (Fully Dilluted)

226m

HALO Sector

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.52

RHY Announcements

Latest Announcements

Date Announcements

02 April 24

Change in substantial holding - Otto Buttula

×

Change in substantial holding - Otto Buttula

27 March 24

Change of Director's Interest Notice - Otto Buttula

×

Change of Director's Interest Notice - Otto Buttula

27 March 24

Change of Director's Interest Notice - Lou Panaccio

×

Change of Director's Interest Notice - Lou Panaccio

27 March 24

Change of Director's Interest Notice - Trevor Lockett

×

Change of Director's Interest Notice - Trevor Lockett

25 March 24

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

21 March 24

Application for quotation of securities - RHY

×

Application for quotation of securities - RHY

21 March 24

Close of Rights Issue

×

Close of Rights Issue

21 March 24

Update - Application for quotation of securities - RHY

×

Update - Application for quotation of securities - RHY

21 March 24

Top 20 securityholders - RHYO options

×

Top 20 securityholders - RHYO options

21 March 24

Distribution schedule - RHYO options

×

Distribution schedule - RHYO options

19 March 24

Internationally Renowned Clinical Advisory Board Established

×

Internationally Renowned Clinical Advisory Board Established

01 March 24

S&P DJI Announces March 2024 Quarterly Rebalance

×

S&P DJI Announces March 2024 Quarterly Rebalance

29 February 24

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

28 February 24

Non-Renounceable Issue - Ineligible Holder Letter

×

Non-Renounceable Issue - Ineligible Holder Letter

27 February 24

Dispatch of Rights Issue Offer Prospectus

×

Dispatch of Rights Issue Offer Prospectus

21 February 24

Rights Issue Investor Presentation

×

Rights Issue Investor Presentation

20 February 24

PAC Partners Appointed Lead Manager

×

PAC Partners Appointed Lead Manager

19 February 24

Prospectus - 2024 Non-Renounceable Rights Issue

×

Prospectus - 2024 Non-Renounceable Rights Issue

19 February 24

Rights Issue - Optionholder Letter

×

Rights Issue - Optionholder Letter

16 February 24

Market Update

×

Market Update

16 February 24

Notification of cessation of securities - RHY

×

Notification of cessation of securities - RHY

12 February 24

EGM Slides

×

EGM Slides

12 February 24

Results of Extraordinary General Meeting

×

Results of Extraordinary General Meeting

09 February 24

Rights Issue Offer to Raise Up To $6.6 million

×

Rights Issue Offer to Raise Up To $6.6 million

09 February 24

Proposed issue of securities - RHY

×

Proposed issue of securities - RHY

RHY Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.04 -0.04 -0.04 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.04 -0.04 -0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock -2.3 -17.7 11.5 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.03 -0.03 -0.02 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.03 -0.03 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.0 2.4 21.3 Lock Lock Lock
     Yield % Lock Lock Lock Lock -3.3 -2.7 -7.9 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.01 0.03 0.03 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.03 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock -47.3 428.4 -24.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 186 210 222 Lock Lock Lock
Basic m Lock Lock Lock Lock 186 210 222 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 8 11 11 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3.8 30.8 -86.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -8 -11 -11 Lock Lock Lock
     Growth % Lock Lock Lock Lock -88.7 -46.9 -1.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -8 -11 -12 Lock Lock Lock
     Growth % Lock Lock Lock Lock -85.8 -45.4 -2.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -8 -11 -11 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -2 -3 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -7 -9 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -64.4 -33.0 6.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -5 -6 -7 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 6 12 4 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -5 -7 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -96.2 -19.2 -8.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 2 8 4 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 3 8 8 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -2 -7 -4 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1 1 2 Lock Lock Lock
Equity $m Lock Lock Lock Lock 2 7 6 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 2 7 6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -7.4 336.9 -21.2 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -215.4 -104.2 -106.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -387.4 -119.3 -139.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -430.6 -243.2 -171.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -372.5 -191.9 -123.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -304.4 -141.8 -104.4 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -6,429.5 N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.3 0.7 0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -133.2 -100.7 -69.5 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.9 8.3 4.0 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 1.9 8.3 2.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 91.2 97.7 58.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -402.2 -696.8 -394.1 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.1 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -215.4 -104.2 -106.8 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.8 1.1 1.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -387.4 -119.3 -139.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -387.4 -119.3 -139.9 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 2,666.2 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A N/A 2,666.2 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 1,448.4 1,585.6 99.5 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -1,448.4 -1,585.6 2,566.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.52%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

-0.10%

3 Month Change

-0.20%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

RHY Shortsell

Frequently Asked Questions

The current share price of Rhythm Biosciences Limited (RHY:ASX) is AU$0.092.
The 52-week high share price for Rhythm Biosciences Limited (RHY:ASX) is AU$0.81.
The 52-week low share price for Rhythm Biosciences Limited (RHY:ASX)? is AU$0.09.
Rhythm Biosciences Limited (RHY:ASX) does not pay a dividend.
Rhythm Biosciences Limited (RHY:ASX) does not pay a dividend.
Rhythm Biosciences Limited (RHY:ASX) does not offer franking credits.
Rhythm Biosciences Limited (RHY:ASX) is classified in the Healthcare.
The current P/E ratio for Rhythm Biosciences Limited (RHY:ASX) is .